pharmaobservatory 0.1.7 → 0.1.9
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +163 -9
- data/docs/AnimalWelfareAssurancesResponse.md +58 -0
- data/docs/{BiomarkerAssayEvidenceResponseBuild.md → AnimalWelfareAssurancesResponseBuild.md} +2 -2
- data/docs/{BiomarkerAssayEvidenceResponseFreshness.md → AnimalWelfareAssurancesResponseFreshness.md} +2 -2
- data/docs/{BiomarkerAssayEvidenceResponseScope.md → AnimalWelfareAssurancesResponseScope.md} +2 -2
- data/docs/AnimalWelfareAssurancesRow.md +48 -0
- data/docs/BiomarkerAlleleFrequenciesResponse.md +58 -0
- data/docs/BiomarkerAlleleFrequenciesRow.md +62 -0
- data/docs/BiomarkerAssayEvidenceResponse.md +3 -3
- data/docs/BiomarkerAssayProvidersResponse.md +58 -0
- data/docs/BiomarkerAssayProvidersRow.md +72 -0
- data/docs/BiomarkerAssayWhitespaceResponse.md +3 -3
- data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
- data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
- data/docs/BiomarkerEvidenceByYearResponse.md +58 -0
- data/docs/BiomarkerEvidenceByYearRow.md +32 -0
- data/docs/BiomarkerEvidenceResponse.md +3 -3
- data/docs/BiomarkerLiteratureResponse.md +3 -3
- data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
- data/docs/BiomarkerRelationsResponse.md +3 -3
- data/docs/BiomarkerSampleCoverageResponse.md +3 -3
- data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
- data/docs/BiomarkerTraversalStatusResponse.md +58 -0
- data/docs/BiomarkerTraversalStatusRow.md +36 -0
- data/docs/BiomarkerValidationResponse.md +3 -3
- data/docs/BiomarkerVariantMentionsResponse.md +3 -3
- data/docs/BiomarkersApi.md +320 -0
- data/docs/BiomarkersRecord.md +2 -2
- data/docs/BiomarkersResponse.md +3 -3
- data/docs/BrandCompaniesResponse.md +3 -3
- data/docs/BrandRevenueResponse.md +3 -3
- data/docs/CatalystsResponse.md +3 -3
- data/docs/CellLinesRecord.md +2 -2
- data/docs/CellLinesResponse.md +3 -3
- data/docs/CliaCertificatesResponse.md +3 -3
- data/docs/CompaniesApi.md +2113 -391
- data/docs/CompaniesRecord.md +2 -2
- data/docs/CompaniesRecordAttributes.md +2 -0
- data/docs/CompaniesResponse.md +3 -3
- data/docs/CompanyAssetsResponse.md +3 -3
- data/docs/CompanyBiomarkerCapabilityResponse.md +58 -0
- data/docs/CompanyBiomarkerCapabilityRow.md +68 -0
- data/docs/CompanyCollaboratorsResponse.md +58 -0
- data/docs/CompanyCollaboratorsRow.md +42 -0
- data/docs/CompanyCompetitorActivityResponse.md +58 -0
- data/docs/CompanyCompetitorActivityRow.md +42 -0
- data/docs/CompanyCompetitorsResponse.md +58 -0
- data/docs/CompanyCompetitorsRow.md +66 -0
- data/docs/CompanyFinancialsResponse.md +58 -0
- data/docs/CompanyFinancialsRow.md +108 -0
- data/docs/CompanyFirmographicsResponse.md +58 -0
- data/docs/CompanyFirmographicsRow.md +80 -0
- data/docs/CompanyFundingEventsResponse.md +3 -3
- data/docs/CompanyFundingSummaryResponse.md +3 -3
- data/docs/CompanyMembersResponse.md +3 -3
- data/docs/CompanyProgramsResponse.md +3 -3
- data/docs/CompanyRareDiseaseDeclarationsResponse.md +58 -0
- data/docs/CompanyRareDiseaseDeclarationsRow.md +52 -0
- data/docs/CompanyTargetsResponse.md +3 -3
- data/docs/CompanyTimelineResponse.md +58 -0
- data/docs/CompanyTimelineRow.md +68 -0
- data/docs/CompanyTrialGeographyResponse.md +3 -3
- data/docs/CompanyTrialSitesResponse.md +3 -3
- data/docs/CompanyUsPatentsResponse.md +58 -0
- data/docs/CompanyUsPatentsRow.md +34 -0
- data/docs/ConditionAdverseEventsResponse.md +3 -3
- data/docs/ConditionBurdenResponse.md +3 -3
- data/docs/ConditionDeliveryResponse.md +3 -3
- data/docs/ConditionDrugsResponse.md +3 -3
- data/docs/ConditionInvestigatorOrganizationsResponse.md +58 -0
- data/docs/ConditionInvestigatorOrganizationsRow.md +44 -0
- data/docs/ConditionPrevalenceResponse.md +3 -3
- data/docs/ConditionPublicationsResponse.md +3 -3
- data/docs/ConditionRecruitmentByPhaseResponse.md +3 -3
- data/docs/ConditionRecruitmentDurationResponse.md +3 -3
- data/docs/ConditionSitesResponse.md +3 -3
- data/docs/ConditionTrialStartForecastResponse.md +3 -3
- data/docs/ConditionTrialsResponse.md +3 -3
- data/docs/ConditionsApi.md +160 -0
- data/docs/ConditionsRecord.md +2 -2
- data/docs/ConditionsResponse.md +3 -3
- data/docs/CroFootprintResponse.md +3 -3
- data/docs/CroTrialsResponse.md +3 -3
- data/docs/DebarmentsResponse.md +3 -3
- data/docs/DrugApprovalsResponse.md +3 -3
- data/docs/DrugAspCodesResponse.md +3 -3
- data/docs/DrugBrandsResponse.md +3 -3
- data/docs/DrugCombinationsResponse.md +3 -3
- data/docs/DrugDeclaredPatentsResponse.md +3 -3
- data/docs/DrugInvestigatorsResponse.md +58 -0
- data/docs/DrugInvestigatorsRow.md +32 -0
- data/docs/DrugLabelSafetyResponse.md +3 -3
- data/docs/DrugMedicareSpendResponse.md +3 -3
- data/docs/DrugPatentCliffResponse.md +3 -3
- data/docs/DrugPatentMentionsResponse.md +3 -3
- data/docs/DrugPatentOwnersResponse.md +3 -3
- data/docs/DrugPricingResponse.md +3 -3
- data/docs/DrugRecallsResponse.md +3 -3
- data/docs/DrugRegulatoryResponse.md +3 -3
- data/docs/DrugSitesResponse.md +3 -3
- data/docs/DrugTargetsResponse.md +3 -3
- data/docs/DrugTrialConditionsResponse.md +3 -3
- data/docs/DrugTrialsResponse.md +3 -3
- data/docs/DrugVariantsResponse.md +3 -3
- data/docs/DrugsApi.md +80 -0
- data/docs/DrugsRecord.md +2 -2
- data/docs/DrugsResponse.md +3 -3
- data/docs/EnforcementEventsResponse.md +3 -3
- data/docs/EnforcementEventsRow.md +22 -4
- data/docs/GxpFacilitiesResponse.md +3 -3
- data/docs/GxpFacilitiesRow.md +49 -1
- data/docs/HospitalBedsYearlyResponse.md +3 -3
- data/docs/HospitalFacilityChangesResponse.md +3 -3
- data/docs/HospitalsApi.md +80 -0
- data/docs/HospitalsRecord.md +2 -2
- data/docs/HospitalsResponse.md +3 -3
- data/docs/ImportRefusalsResponse.md +3 -3
- data/docs/InspectionFindingsResponse.md +3 -3
- data/docs/InspectionsResponse.md +3 -3
- data/docs/InstitutionalHoldingsResponse.md +3 -3
- data/docs/InstitutionalQuarterTotalsResponse.md +3 -3
- data/docs/InvestigatorConditionsResponse.md +58 -0
- data/docs/InvestigatorConditionsRow.md +28 -0
- data/docs/InvestigatorDebarmentsResponse.md +58 -0
- data/docs/InvestigatorDebarmentsRow.md +32 -0
- data/docs/InvestigatorHospitalsResponse.md +58 -0
- data/docs/InvestigatorHospitalsRow.md +28 -0
- data/docs/InvestigatorInspectionsResponse.md +58 -0
- data/docs/InvestigatorInspectionsRow.md +46 -0
- data/docs/InvestigatorPublicationsResponse.md +58 -0
- data/docs/InvestigatorPublicationsRow.md +34 -0
- data/docs/InvestigatorTopicsResponse.md +58 -0
- data/docs/InvestigatorTopicsRow.md +34 -0
- data/docs/InvestigatorTrialsResponse.md +58 -0
- data/docs/InvestigatorTrialsRow.md +64 -0
- data/docs/InvestigatorsApi.md +1113 -0
- data/docs/InvestigatorsRecord.md +38 -0
- data/docs/InvestigatorsResponse.md +58 -0
- data/docs/InvestigatorsRow.md +70 -0
- data/docs/InvestorFundsResponse.md +3 -3
- data/docs/InvestorPortfolioResponse.md +3 -3
- data/docs/InvestorPrivateFundsResponse.md +3 -3
- data/docs/InvestorsRecord.md +2 -2
- data/docs/InvestorsResponse.md +3 -3
- data/docs/InvestorsRow.md +6 -0
- data/docs/LegalEntitiesApi.md +1401 -281
- data/docs/LegalEntitiesRecord.md +2 -2
- data/docs/LegalEntitiesRecordAttributes.md +6 -0
- data/docs/LegalEntitiesResponse.md +3 -3
- data/docs/LegalEntitySecFilingsResponse.md +58 -0
- data/docs/LegalEntitySecFilingsRow.md +44 -0
- data/docs/ManagersRecord.md +2 -2
- data/docs/ManagersResponse.md +3 -3
- data/docs/OrgDisclosureTrendResponse.md +58 -0
- data/docs/OrgDisclosureTrendRow.md +62 -0
- data/docs/OrgDisclosuresResponse.md +3 -3
- data/docs/OrgRelationshipsResponse.md +3 -3
- data/docs/OwnershipObservationsResponse.md +58 -0
- data/docs/OwnershipObservationsRow.md +168 -0
- data/docs/OwnershipPercentagesResponse.md +3 -3
- data/docs/OwnershipPositionsResponse.md +3 -3
- data/docs/OwnershipSourceCoverageResponse.md +58 -0
- data/docs/OwnershipSourceCoverageRow.md +62 -0
- data/docs/PdufaDatesResponse.md +3 -3
- data/docs/ProgramLicensingCandidatesResponse.md +3 -3
- data/docs/ProgramsResponse.md +3 -3
- data/docs/RareDiseaseGenesResponse.md +3 -3
- data/docs/RareDiseaseHierarchyResponse.md +3 -3
- data/docs/RareDiseaseInvestigatorCoverageResponse.md +3 -3
- data/docs/RareDiseaseInvestigatorsResponse.md +3 -3
- data/docs/RareDiseaseMappingsResponse.md +3 -3
- data/docs/RareDiseaseOrganizationsResponse.md +3 -3
- data/docs/RareDiseasePrevalenceResponse.md +3 -3
- data/docs/RareDiseaseRarityEvidenceResponse.md +3 -3
- data/docs/RareDiseaseRarityResponse.md +3 -3
- data/docs/RareDiseaseReplacementsResponse.md +3 -3
- data/docs/RareDiseaseSiteCoverageResponse.md +3 -3
- data/docs/RareDiseaseSponsorsResponse.md +3 -3
- data/docs/RareDiseaseTrialCoverageResponse.md +3 -3
- data/docs/RareDiseaseTrialSitesResponse.md +3 -3
- data/docs/RareDiseaseTrialsResponse.md +3 -3
- data/docs/RareDiseasesRecord.md +2 -2
- data/docs/RareDiseasesResponse.md +3 -3
- data/docs/RecallsResponse.md +3 -3
- data/docs/RwdConductorDeliveryResponse.md +58 -0
- data/docs/RwdConductorDeliveryRow.md +74 -0
- data/docs/RwdConductorFootprintResponse.md +58 -0
- data/docs/RwdConductorFootprintRow.md +40 -0
- data/docs/RwdConductorStudiesResponse.md +58 -0
- data/docs/RwdConductorStudiesRow.md +42 -0
- data/docs/RwdConductorsApi.md +393 -0
- data/docs/RwdConductorsRecord.md +38 -0
- data/docs/RwdConductorsResponse.md +58 -0
- data/docs/RwdConductorsRow.md +72 -0
- data/docs/RwdCoverageResponse.md +3 -3
- data/docs/RwdInstitutionsApi.md +153 -0
- data/docs/RwdInstitutionsRecord.md +38 -0
- data/docs/RwdInstitutionsResponse.md +58 -0
- data/docs/RwdInstitutionsRow.md +154 -0
- data/docs/RwdNetworksApi.md +153 -0
- data/docs/RwdNetworksRecord.md +38 -0
- data/docs/RwdNetworksResponse.md +58 -0
- data/docs/RwdNetworksRow.md +110 -0
- data/docs/RwdRegisterProvenanceResponse.md +3 -3
- data/docs/RwdRegistersRecord.md +2 -2
- data/docs/RwdSourceAgeBandsResponse.md +3 -3
- data/docs/RwdSourceConditionsResponse.md +3 -3
- data/docs/RwdSourceEtlMappingsResponse.md +3 -3
- data/docs/RwdSourceLinkagesResponse.md +3 -3
- data/docs/RwdSourceTypesResponse.md +3 -3
- data/docs/RwdSourceVocabulariesResponse.md +3 -3
- data/docs/RwdSourcesRecord.md +2 -2
- data/docs/RwdSourcesResponse.md +3 -3
- data/docs/RwdStudiesApi.md +80 -0
- data/docs/RwdStudiesRecord.md +2 -2
- data/docs/RwdStudiesResponse.md +3 -3
- data/docs/RwdStudyConditionsResponse.md +3 -3
- data/docs/RwdStudyDataSourcesResponse.md +3 -3
- data/docs/RwdStudyDrugsResponse.md +3 -3
- data/docs/RwdStudyMilestonesResponse.md +3 -3
- data/docs/RwdWithheldFieldsResponse.md +3 -3
- data/docs/SbtiCrosscheckResponse.md +58 -0
- data/docs/SbtiCrosscheckRow.md +48 -0
- data/docs/SecPdufaDatesResponse.md +3 -3
- data/docs/SiteBedsYearlyResponse.md +3 -3
- data/docs/SiteCroTrialsResponse.md +3 -3
- data/docs/SiteHospitalsResponse.md +3 -3
- data/docs/SiteInvestigatorsResponse.md +3 -3
- data/docs/SiteTrialConditionsResponse.md +3 -3
- data/docs/SiteTrialDrugsResponse.md +3 -3
- data/docs/SiteTrialsResponse.md +3 -3
- data/docs/SitesRecord.md +2 -2
- data/docs/SitesResponse.md +3 -3
- data/docs/SponsorDeliveryResponse.md +58 -0
- data/docs/SponsorDeliveryRow.md +52 -0
- data/docs/SponsorPatentMentionsResponse.md +58 -0
- data/docs/SponsorPatentMentionsRow.md +42 -0
- data/docs/SponsorPublicationsResponse.md +58 -0
- data/docs/SponsorPublicationsRow.md +42 -0
- data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
- data/docs/SponsorRecruitmentDurationResponse.md +3 -3
- data/docs/SponsorTrialConditionsResponse.md +58 -0
- data/docs/SponsorTrialConditionsRow.md +36 -0
- data/docs/SponsorTrialDrugsResponse.md +58 -0
- data/docs/SponsorTrialDrugsRow.md +34 -0
- data/docs/SponsorTrialStartForecastResponse.md +3 -3
- data/docs/SponsorTrialsResponse.md +3 -3
- data/docs/SupplierCapabilityEsgResponse.md +3 -3
- data/docs/SupplierServicesResponse.md +3 -3
- data/docs/SupplierSitesResponse.md +3 -3
- data/docs/SuppliersRecord.md +2 -2
- data/docs/SuppliersResponse.md +3 -3
- data/docs/SuppliersRow.md +2 -0
- data/docs/TargetAssociationsResponse.md +3 -3
- data/docs/TargetCrowdingResponse.md +3 -3
- data/docs/TargetDrugsResponse.md +3 -3
- data/docs/TargetEvidenceResponse.md +3 -3
- data/docs/TargetInvestigatorsResponse.md +58 -0
- data/docs/TargetInvestigatorsRow.md +30 -0
- data/docs/TargetPatentMentionsResponse.md +3 -3
- data/docs/TargetProgramsResponse.md +3 -3
- data/docs/TargetPublicationsResponse.md +3 -3
- data/docs/TargetRegulatoryPrecedentResponse.md +3 -3
- data/docs/TargetTrialsResponse.md +3 -3
- data/docs/TargetsApi.md +80 -0
- data/docs/TargetsRecord.md +2 -2
- data/docs/TargetsResponse.md +3 -3
- data/docs/TrialAdverseEventsResponse.md +3 -3
- data/docs/TrialChangesResponse.md +3 -3
- data/docs/TrialDeliveryResponse.md +3 -3
- data/docs/TrialDemographicsResponse.md +3 -3
- data/docs/TrialDrugClassesResponse.md +3 -3
- data/docs/TrialDrugsResponse.md +3 -3
- data/docs/TrialEnrollmentHistoryResponse.md +3 -3
- data/docs/TrialEnrollmentRateResponse.md +3 -3
- data/docs/TrialExtractedEndpointsResponse.md +3 -3
- data/docs/TrialKolsResponse.md +3 -3
- data/docs/TrialOutcomeMeasuresResponse.md +3 -3
- data/docs/TrialResearchPaymentsResponse.md +3 -3
- data/docs/TrialSiteHistoryResponse.md +3 -3
- data/docs/TrialSitesResponse.md +3 -3
- data/docs/TrialsRecord.md +2 -2
- data/docs/TrialsResponse.md +3 -3
- data/docs/UnmatchedProductRevenueResponse.md +3 -3
- data/docs/UntitledLettersResponse.md +3 -3
- data/docs/WarningLettersResponse.md +3 -3
- data/lib/pharmaobservatory/api/biomarkers_api.rb +336 -0
- data/lib/pharmaobservatory/api/companies_api.rb +2360 -449
- data/lib/pharmaobservatory/api/conditions_api.rb +168 -0
- data/lib/pharmaobservatory/api/drugs_api.rb +84 -0
- data/lib/pharmaobservatory/api/hospitals_api.rb +84 -0
- data/lib/pharmaobservatory/api/investigators_api.rb +1169 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +1460 -284
- data/lib/pharmaobservatory/api/rwd_conductors_api.rb +413 -0
- data/lib/pharmaobservatory/api/rwd_institutions_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_networks_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_studies_api.rb +84 -0
- data/lib/pharmaobservatory/api/targets_api.rb +84 -0
- data/lib/pharmaobservatory/models/animal_welfare_assurances_response.rb +478 -0
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_build.rb → animal_welfare_assurances_response_build.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_freshness.rb → animal_welfare_assurances_response_freshness.rb} +3 -3
- data/lib/pharmaobservatory/models/{biomarker_assay_evidence_response_scope.rb → animal_welfare_assurances_response_scope.rb} +3 -3
- data/lib/pharmaobservatory/models/animal_welfare_assurances_row.rb +392 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb +465 -0
- data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_assay_providers_row.rb +520 -0
- data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb +300 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_traversal_status_row.rb +322 -0
- data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
- data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
- data/lib/pharmaobservatory/models/brand_companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/brand_revenue_response.rb +3 -3
- data/lib/pharmaobservatory/models/catalysts_response.rb +3 -3
- data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
- data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
- data/lib/pharmaobservatory/models/clia_certificates_response.rb +3 -3
- data/lib/pharmaobservatory/models/companies_record.rb +2 -2
- data/lib/pharmaobservatory/models/companies_record_attributes.rb +10 -1
- data/lib/pharmaobservatory/models/companies_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_biomarker_capability_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_collaborators_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_collaborators_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_competitor_activity_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_competitor_activity_row.rb +355 -0
- data/lib/pharmaobservatory/models/company_competitors_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_competitors_row.rb +493 -0
- data/lib/pharmaobservatory/models/company_financials_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_financials_row.rb +718 -0
- data/lib/pharmaobservatory/models/company_firmographics_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_firmographics_row.rb +566 -0
- data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb +410 -0
- data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_timeline_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_timeline_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_trial_geography_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/company_us_patents_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_us_patents_row.rb +311 -0
- data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_investigator_organizations_response.rb +478 -0
- data/lib/pharmaobservatory/models/condition_investigator_organizations_row.rb +366 -0
- data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
- data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/cro_footprint_response.rb +3 -3
- data/lib/pharmaobservatory/models/cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/debarments_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_approvals_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_asp_codes_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_brands_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_combinations_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_declared_patents_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_investigators_row.rb +302 -0
- data/lib/pharmaobservatory/models/drug_label_safety_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_medicare_spend_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_patent_owners_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_pricing_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_recalls_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_regulatory_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/drug_variants_response.rb +3 -3
- data/lib/pharmaobservatory/models/drugs_record.rb +2 -2
- data/lib/pharmaobservatory/models/drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/enforcement_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/enforcement_events_row.rb +104 -5
- data/lib/pharmaobservatory/models/gxp_facilities_response.rb +3 -3
- data/lib/pharmaobservatory/models/gxp_facilities_row.rb +266 -2
- data/lib/pharmaobservatory/models/hospital_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/hospital_facility_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/hospitals_record.rb +2 -2
- data/lib/pharmaobservatory/models/hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/import_refusals_response.rb +3 -3
- data/lib/pharmaobservatory/models/inspection_findings_response.rb +3 -3
- data/lib/pharmaobservatory/models/inspections_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
- data/lib/pharmaobservatory/models/institutional_quarter_totals_response.rb +3 -3
- data/lib/pharmaobservatory/models/investigator_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_conditions_row.rb +278 -0
- data/lib/pharmaobservatory/models/investigator_debarments_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_debarments_row.rb +300 -0
- data/lib/pharmaobservatory/models/investigator_hospitals_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_hospitals_row.rb +280 -0
- data/lib/pharmaobservatory/models/investigator_inspections_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_inspections_row.rb +377 -0
- data/lib/pharmaobservatory/models/investigator_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_publications_row.rb +311 -0
- data/lib/pharmaobservatory/models/investigator_topics_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_topics_row.rb +311 -0
- data/lib/pharmaobservatory/models/investigator_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigator_trials_row.rb +478 -0
- data/lib/pharmaobservatory/models/investigators_record.rb +385 -0
- data/lib/pharmaobservatory/models/investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/investigators_row.rb +511 -0
- data/lib/pharmaobservatory/models/investor_funds_response.rb +3 -3
- data/lib/pharmaobservatory/models/investor_portfolio_response.rb +3 -3
- data/lib/pharmaobservatory/models/investor_private_funds_response.rb +3 -3
- data/lib/pharmaobservatory/models/investors_record.rb +2 -2
- data/lib/pharmaobservatory/models/investors_response.rb +3 -3
- data/lib/pharmaobservatory/models/investors_row.rb +34 -1
- data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
- data/lib/pharmaobservatory/models/legal_entities_record_attributes.rb +28 -1
- data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +478 -0
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb +370 -0
- data/lib/pharmaobservatory/models/managers_record.rb +2 -2
- data/lib/pharmaobservatory/models/managers_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_disclosure_trend_row.rb +465 -0
- data/lib/pharmaobservatory/models/org_disclosures_response.rb +3 -3
- data/lib/pharmaobservatory/models/org_relationships_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_observations_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_observations_row.rb +1048 -0
- data/lib/pharmaobservatory/models/ownership_percentages_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
- data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_source_coverage_row.rb +465 -0
- data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/program_licensing_candidates_response.rb +3 -3
- data/lib/pharmaobservatory/models/programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_genes_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_hierarchy_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_mappings_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_organizations_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_prevalence_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_rarity_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_replacements_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_site_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_sponsors_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trial_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_disease_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/rare_diseases_record.rb +2 -2
- data/lib/pharmaobservatory/models/rare_diseases_response.rb +3 -3
- data/lib/pharmaobservatory/models/recalls_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb +537 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb +346 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_row.rb +355 -0
- data/lib/pharmaobservatory/models/rwd_conductors_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_conductors_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductors_row.rb +526 -0
- data/lib/pharmaobservatory/models/rwd_coverage_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_institutions_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_institutions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_institutions_row.rb +981 -0
- data/lib/pharmaobservatory/models/rwd_networks_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_networks_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_networks_row.rb +733 -0
- data/lib/pharmaobservatory/models/rwd_register_provenance_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_registers_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_source_age_bands_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_etl_mappings_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_linkages_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_types_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_source_vocabularies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_sources_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_sources_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_studies_record.rb +2 -2
- data/lib/pharmaobservatory/models/rwd_studies_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_data_sources_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_study_milestones_response.rb +3 -3
- data/lib/pharmaobservatory/models/rwd_withheld_fields_response.rb +3 -3
- data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +478 -0
- data/lib/pharmaobservatory/models/sbti_crosscheck_row.rb +388 -0
- data/lib/pharmaobservatory/models/sec_pdufa_dates_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/sites_record.rb +2 -2
- data/lib/pharmaobservatory/models/sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_delivery_row.rb +410 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_publications_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_publications_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb +322 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb +311 -0
- data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
- data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_services_response.rb +3 -3
- data/lib/pharmaobservatory/models/supplier_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/suppliers_record.rb +2 -2
- data/lib/pharmaobservatory/models/suppliers_response.rb +3 -3
- data/lib/pharmaobservatory/models/suppliers_row.rb +12 -1
- data/lib/pharmaobservatory/models/target_associations_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_crowding_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_evidence_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/target_investigators_row.rb +291 -0
- data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_programs_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_publications_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +3 -3
- data/lib/pharmaobservatory/models/target_trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/targets_record.rb +2 -2
- data/lib/pharmaobservatory/models/targets_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_kols_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_research_payments_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_site_history_response.rb +3 -3
- data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
- data/lib/pharmaobservatory/models/trials_record.rb +2 -2
- data/lib/pharmaobservatory/models/trials_response.rb +3 -3
- data/lib/pharmaobservatory/models/unmatched_product_revenue_response.rb +3 -3
- data/lib/pharmaobservatory/models/untitled_letters_response.rb +3 -3
- data/lib/pharmaobservatory/models/warning_letters_response.rb +3 -3
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +93 -3
- metadata +188 -8
|
@@ -0,0 +1,718 @@
|
|
|
1
|
+
=begin
|
|
2
|
+
#Pharma Observatory Public REST API
|
|
3
|
+
|
|
4
|
+
#Read-only REST API over the Pharma Observatory biomedical data platform. Reference: https://pharmaobservatory.com/api-reference
|
|
5
|
+
|
|
6
|
+
The version of the OpenAPI document: 1.0.0
|
|
7
|
+
|
|
8
|
+
Generated by: https://openapi-generator.tech
|
|
9
|
+
Generator version: 7.13.0
|
|
10
|
+
|
|
11
|
+
=end
|
|
12
|
+
|
|
13
|
+
require 'date'
|
|
14
|
+
require 'time'
|
|
15
|
+
|
|
16
|
+
module PharmaObservatory
|
|
17
|
+
# One row of the company_financials dataset: one row per filing organization record and fiscal year. A grouped request returns the group columns and the measures instead, as additional properties.
|
|
18
|
+
class CompanyFinancialsRow
|
|
19
|
+
# Company level: the company the row is about; the entry key for the companies object type.
|
|
20
|
+
attr_accessor :company_id
|
|
21
|
+
|
|
22
|
+
# Display name of the company.
|
|
23
|
+
attr_accessor :company_name
|
|
24
|
+
|
|
25
|
+
# Group level: the company's current ultimate parent; a root's group is itself.
|
|
26
|
+
attr_accessor :group_id
|
|
27
|
+
|
|
28
|
+
# Display name of the group.
|
|
29
|
+
attr_accessor :group_name
|
|
30
|
+
|
|
31
|
+
# Legal-entity level: the organization record that filed (the SEC filer).
|
|
32
|
+
attr_accessor :reporting_org_id
|
|
33
|
+
|
|
34
|
+
# The fiscal year the figures belong to.
|
|
35
|
+
attr_accessor :fiscal_year
|
|
36
|
+
|
|
37
|
+
# True when the record has an SEC registration number and is a listed filer (a Form D issuer that is not listed is false).
|
|
38
|
+
attr_accessor :is_public
|
|
39
|
+
|
|
40
|
+
# The SEC registration number (CIK, Central Index Key) of the filer.
|
|
41
|
+
attr_accessor :edgar_cik
|
|
42
|
+
|
|
43
|
+
# The stock ticker.
|
|
44
|
+
attr_accessor :ticker
|
|
45
|
+
|
|
46
|
+
# The primary exchange listing.
|
|
47
|
+
attr_accessor :exchange
|
|
48
|
+
|
|
49
|
+
# The latest reported public float, in USD, repeated on every year row of the filer (a proxy for market value, not a live market capitalization).
|
|
50
|
+
attr_accessor :public_float_usd
|
|
51
|
+
|
|
52
|
+
# The fiscal year of public_float_usd.
|
|
53
|
+
attr_accessor :public_float_fy
|
|
54
|
+
|
|
55
|
+
# The latest reported cover-page share count of the filer, repeated on every year row (the denominator of an ownership percentage).
|
|
56
|
+
attr_accessor :latest_shares_outstanding
|
|
57
|
+
|
|
58
|
+
# The fiscal year of latest_shares_outstanding.
|
|
59
|
+
attr_accessor :latest_shares_outstanding_fy
|
|
60
|
+
|
|
61
|
+
# The latest fiscal year the filer reported any line item.
|
|
62
|
+
attr_accessor :latest_financial_fy
|
|
63
|
+
|
|
64
|
+
# Total revenue for the fiscal year, in USD (a non-USD filer is converted at the calendar-year average rate; null when no rate exists).
|
|
65
|
+
attr_accessor :revenue
|
|
66
|
+
|
|
67
|
+
# Net income for the fiscal year, in USD.
|
|
68
|
+
attr_accessor :net_income
|
|
69
|
+
|
|
70
|
+
# Research and development expense for the fiscal year, in USD.
|
|
71
|
+
attr_accessor :rnd
|
|
72
|
+
|
|
73
|
+
# Total assets at the fiscal year end, in USD (converted at the year-end rate).
|
|
74
|
+
attr_accessor :assets
|
|
75
|
+
|
|
76
|
+
# Stockholders' equity at the fiscal year end, in USD.
|
|
77
|
+
attr_accessor :equity
|
|
78
|
+
|
|
79
|
+
# The public float on the annual report cover (the value of shares held by non-affiliates at the most recent second fiscal quarter end), in USD, anchored to the fiscal year it was filed with.
|
|
80
|
+
attr_accessor :public_float
|
|
81
|
+
|
|
82
|
+
# Cash and cash equivalents at the fiscal year end, in USD.
|
|
83
|
+
attr_accessor :cash
|
|
84
|
+
|
|
85
|
+
# Short-term investments at the fiscal year end, in USD.
|
|
86
|
+
attr_accessor :short_term_investments
|
|
87
|
+
|
|
88
|
+
# Cash plus short-term investments (a missing investments line counts as zero), in USD; null when cash is null.
|
|
89
|
+
attr_accessor :cash_and_investments
|
|
90
|
+
|
|
91
|
+
# Net cash from operating activities for the fiscal year, in USD; negative means burning.
|
|
92
|
+
attr_accessor :operating_cash_flow
|
|
93
|
+
|
|
94
|
+
# Shares outstanding on the annual report cover date, a count (never currency-converted); the cover date falls 0 to 3 months after the fiscal year end.
|
|
95
|
+
attr_accessor :shares_outstanding
|
|
96
|
+
|
|
97
|
+
# Stock-based compensation expense, in USD.
|
|
98
|
+
attr_accessor :stock_based_compensation
|
|
99
|
+
|
|
100
|
+
# Operating expenses, in USD.
|
|
101
|
+
attr_accessor :operating_expenses
|
|
102
|
+
|
|
103
|
+
# Dividends paid, in USD, as filed with no sign test (filers differ on whether an outflow is positive or negative).
|
|
104
|
+
attr_accessor :dividends_paid
|
|
105
|
+
|
|
106
|
+
# Basic earnings per share, in USD.
|
|
107
|
+
attr_accessor :eps_basic
|
|
108
|
+
|
|
109
|
+
# Diluted earnings per share, in USD.
|
|
110
|
+
attr_accessor :eps_diluted
|
|
111
|
+
|
|
112
|
+
# Total liabilities at the fiscal year end, in USD.
|
|
113
|
+
attr_accessor :total_liabilities
|
|
114
|
+
|
|
115
|
+
# The non-current portion of long-term debt, in USD (null for a filer that reports only a total).
|
|
116
|
+
attr_accessor :long_term_debt_noncurrent
|
|
117
|
+
|
|
118
|
+
# Long-term debt, current plus non-current, in USD.
|
|
119
|
+
attr_accessor :long_term_debt_total
|
|
120
|
+
|
|
121
|
+
# Intangible assets, in USD.
|
|
122
|
+
attr_accessor :intangible_assets
|
|
123
|
+
|
|
124
|
+
# Property, plant and equipment, in USD.
|
|
125
|
+
attr_accessor :property_plant_equipment
|
|
126
|
+
|
|
127
|
+
# Goodwill, in USD.
|
|
128
|
+
attr_accessor :goodwill
|
|
129
|
+
|
|
130
|
+
# Inventory, in USD.
|
|
131
|
+
attr_accessor :inventory
|
|
132
|
+
|
|
133
|
+
# Accounts payable, in USD.
|
|
134
|
+
attr_accessor :accounts_payable
|
|
135
|
+
|
|
136
|
+
# Accounts receivable, in USD.
|
|
137
|
+
attr_accessor :accounts_receivable
|
|
138
|
+
|
|
139
|
+
# Weighted average basic shares, a count.
|
|
140
|
+
attr_accessor :weighted_average_shares_basic
|
|
141
|
+
|
|
142
|
+
# Weighted average diluted shares, a count.
|
|
143
|
+
attr_accessor :weighted_average_shares_diluted
|
|
144
|
+
|
|
145
|
+
# The average operating cash flow over this fiscal year and the two before it (the years reported), in USD; negative means burning.
|
|
146
|
+
attr_accessor :burn_basis_usd
|
|
147
|
+
|
|
148
|
+
# How many reported years burn_basis_usd averages over, 1 to 3.
|
|
149
|
+
attr_accessor :burn_basis_years
|
|
150
|
+
|
|
151
|
+
# Derived, not reported: cash_and_investments divided by the monthly burn (burn_basis_usd over 12), in months, rounded to 0.1. Null when the filer generated cash or has no cash figure.
|
|
152
|
+
attr_accessor :runway_months
|
|
153
|
+
|
|
154
|
+
# The filing-level total revenue extracted from the 10-K or 20-F, in USD millions (the line the revenue-by-drug chart draws over the per-product stack); null where no total was extracted.
|
|
155
|
+
attr_accessor :sec_total_revenue_usd_millions
|
|
156
|
+
|
|
157
|
+
# Attribute mapping from ruby-style variable name to JSON key.
|
|
158
|
+
def self.attribute_map
|
|
159
|
+
{
|
|
160
|
+
:'company_id' => :'company_id',
|
|
161
|
+
:'company_name' => :'company_name',
|
|
162
|
+
:'group_id' => :'group_id',
|
|
163
|
+
:'group_name' => :'group_name',
|
|
164
|
+
:'reporting_org_id' => :'reporting_org_id',
|
|
165
|
+
:'fiscal_year' => :'fiscal_year',
|
|
166
|
+
:'is_public' => :'is_public',
|
|
167
|
+
:'edgar_cik' => :'edgar_cik',
|
|
168
|
+
:'ticker' => :'ticker',
|
|
169
|
+
:'exchange' => :'exchange',
|
|
170
|
+
:'public_float_usd' => :'public_float_usd',
|
|
171
|
+
:'public_float_fy' => :'public_float_fy',
|
|
172
|
+
:'latest_shares_outstanding' => :'latest_shares_outstanding',
|
|
173
|
+
:'latest_shares_outstanding_fy' => :'latest_shares_outstanding_fy',
|
|
174
|
+
:'latest_financial_fy' => :'latest_financial_fy',
|
|
175
|
+
:'revenue' => :'revenue',
|
|
176
|
+
:'net_income' => :'net_income',
|
|
177
|
+
:'rnd' => :'rnd',
|
|
178
|
+
:'assets' => :'assets',
|
|
179
|
+
:'equity' => :'equity',
|
|
180
|
+
:'public_float' => :'public_float',
|
|
181
|
+
:'cash' => :'cash',
|
|
182
|
+
:'short_term_investments' => :'short_term_investments',
|
|
183
|
+
:'cash_and_investments' => :'cash_and_investments',
|
|
184
|
+
:'operating_cash_flow' => :'operating_cash_flow',
|
|
185
|
+
:'shares_outstanding' => :'shares_outstanding',
|
|
186
|
+
:'stock_based_compensation' => :'stock_based_compensation',
|
|
187
|
+
:'operating_expenses' => :'operating_expenses',
|
|
188
|
+
:'dividends_paid' => :'dividends_paid',
|
|
189
|
+
:'eps_basic' => :'eps_basic',
|
|
190
|
+
:'eps_diluted' => :'eps_diluted',
|
|
191
|
+
:'total_liabilities' => :'total_liabilities',
|
|
192
|
+
:'long_term_debt_noncurrent' => :'long_term_debt_noncurrent',
|
|
193
|
+
:'long_term_debt_total' => :'long_term_debt_total',
|
|
194
|
+
:'intangible_assets' => :'intangible_assets',
|
|
195
|
+
:'property_plant_equipment' => :'property_plant_equipment',
|
|
196
|
+
:'goodwill' => :'goodwill',
|
|
197
|
+
:'inventory' => :'inventory',
|
|
198
|
+
:'accounts_payable' => :'accounts_payable',
|
|
199
|
+
:'accounts_receivable' => :'accounts_receivable',
|
|
200
|
+
:'weighted_average_shares_basic' => :'weighted_average_shares_basic',
|
|
201
|
+
:'weighted_average_shares_diluted' => :'weighted_average_shares_diluted',
|
|
202
|
+
:'burn_basis_usd' => :'burn_basis_usd',
|
|
203
|
+
:'burn_basis_years' => :'burn_basis_years',
|
|
204
|
+
:'runway_months' => :'runway_months',
|
|
205
|
+
:'sec_total_revenue_usd_millions' => :'sec_total_revenue_usd_millions'
|
|
206
|
+
}
|
|
207
|
+
end
|
|
208
|
+
|
|
209
|
+
# Returns attribute mapping this model knows about
|
|
210
|
+
def self.acceptable_attribute_map
|
|
211
|
+
attribute_map
|
|
212
|
+
end
|
|
213
|
+
|
|
214
|
+
# Returns all the JSON keys this model knows about
|
|
215
|
+
def self.acceptable_attributes
|
|
216
|
+
acceptable_attribute_map.values
|
|
217
|
+
end
|
|
218
|
+
|
|
219
|
+
# Attribute type mapping.
|
|
220
|
+
def self.openapi_types
|
|
221
|
+
{
|
|
222
|
+
:'company_id' => :'String',
|
|
223
|
+
:'company_name' => :'String',
|
|
224
|
+
:'group_id' => :'String',
|
|
225
|
+
:'group_name' => :'String',
|
|
226
|
+
:'reporting_org_id' => :'String',
|
|
227
|
+
:'fiscal_year' => :'Integer',
|
|
228
|
+
:'is_public' => :'Boolean',
|
|
229
|
+
:'edgar_cik' => :'String',
|
|
230
|
+
:'ticker' => :'String',
|
|
231
|
+
:'exchange' => :'String',
|
|
232
|
+
:'public_float_usd' => :'Float',
|
|
233
|
+
:'public_float_fy' => :'Integer',
|
|
234
|
+
:'latest_shares_outstanding' => :'Float',
|
|
235
|
+
:'latest_shares_outstanding_fy' => :'Integer',
|
|
236
|
+
:'latest_financial_fy' => :'Integer',
|
|
237
|
+
:'revenue' => :'Float',
|
|
238
|
+
:'net_income' => :'Float',
|
|
239
|
+
:'rnd' => :'Float',
|
|
240
|
+
:'assets' => :'Float',
|
|
241
|
+
:'equity' => :'Float',
|
|
242
|
+
:'public_float' => :'Float',
|
|
243
|
+
:'cash' => :'Float',
|
|
244
|
+
:'short_term_investments' => :'Float',
|
|
245
|
+
:'cash_and_investments' => :'Float',
|
|
246
|
+
:'operating_cash_flow' => :'Float',
|
|
247
|
+
:'shares_outstanding' => :'Float',
|
|
248
|
+
:'stock_based_compensation' => :'Float',
|
|
249
|
+
:'operating_expenses' => :'Float',
|
|
250
|
+
:'dividends_paid' => :'Float',
|
|
251
|
+
:'eps_basic' => :'Float',
|
|
252
|
+
:'eps_diluted' => :'Float',
|
|
253
|
+
:'total_liabilities' => :'Float',
|
|
254
|
+
:'long_term_debt_noncurrent' => :'Float',
|
|
255
|
+
:'long_term_debt_total' => :'Float',
|
|
256
|
+
:'intangible_assets' => :'Float',
|
|
257
|
+
:'property_plant_equipment' => :'Float',
|
|
258
|
+
:'goodwill' => :'Float',
|
|
259
|
+
:'inventory' => :'Float',
|
|
260
|
+
:'accounts_payable' => :'Float',
|
|
261
|
+
:'accounts_receivable' => :'Float',
|
|
262
|
+
:'weighted_average_shares_basic' => :'Float',
|
|
263
|
+
:'weighted_average_shares_diluted' => :'Float',
|
|
264
|
+
:'burn_basis_usd' => :'Float',
|
|
265
|
+
:'burn_basis_years' => :'Integer',
|
|
266
|
+
:'runway_months' => :'Float',
|
|
267
|
+
:'sec_total_revenue_usd_millions' => :'Float'
|
|
268
|
+
}
|
|
269
|
+
end
|
|
270
|
+
|
|
271
|
+
# List of attributes with nullable: true
|
|
272
|
+
def self.openapi_nullable
|
|
273
|
+
Set.new([
|
|
274
|
+
:'company_id',
|
|
275
|
+
:'company_name',
|
|
276
|
+
:'group_id',
|
|
277
|
+
:'group_name',
|
|
278
|
+
:'reporting_org_id',
|
|
279
|
+
:'fiscal_year',
|
|
280
|
+
:'is_public',
|
|
281
|
+
:'edgar_cik',
|
|
282
|
+
:'ticker',
|
|
283
|
+
:'exchange',
|
|
284
|
+
:'public_float_usd',
|
|
285
|
+
:'public_float_fy',
|
|
286
|
+
:'latest_shares_outstanding',
|
|
287
|
+
:'latest_shares_outstanding_fy',
|
|
288
|
+
:'latest_financial_fy',
|
|
289
|
+
:'revenue',
|
|
290
|
+
:'net_income',
|
|
291
|
+
:'rnd',
|
|
292
|
+
:'assets',
|
|
293
|
+
:'equity',
|
|
294
|
+
:'public_float',
|
|
295
|
+
:'cash',
|
|
296
|
+
:'short_term_investments',
|
|
297
|
+
:'cash_and_investments',
|
|
298
|
+
:'operating_cash_flow',
|
|
299
|
+
:'shares_outstanding',
|
|
300
|
+
:'stock_based_compensation',
|
|
301
|
+
:'operating_expenses',
|
|
302
|
+
:'dividends_paid',
|
|
303
|
+
:'eps_basic',
|
|
304
|
+
:'eps_diluted',
|
|
305
|
+
:'total_liabilities',
|
|
306
|
+
:'long_term_debt_noncurrent',
|
|
307
|
+
:'long_term_debt_total',
|
|
308
|
+
:'intangible_assets',
|
|
309
|
+
:'property_plant_equipment',
|
|
310
|
+
:'goodwill',
|
|
311
|
+
:'inventory',
|
|
312
|
+
:'accounts_payable',
|
|
313
|
+
:'accounts_receivable',
|
|
314
|
+
:'weighted_average_shares_basic',
|
|
315
|
+
:'weighted_average_shares_diluted',
|
|
316
|
+
:'burn_basis_usd',
|
|
317
|
+
:'burn_basis_years',
|
|
318
|
+
:'runway_months',
|
|
319
|
+
:'sec_total_revenue_usd_millions'
|
|
320
|
+
])
|
|
321
|
+
end
|
|
322
|
+
|
|
323
|
+
# Initializes the object
|
|
324
|
+
# @param [Hash] attributes Model attributes in the form of hash
|
|
325
|
+
def initialize(attributes = {})
|
|
326
|
+
if (!attributes.is_a?(Hash))
|
|
327
|
+
fail ArgumentError, "The input argument (attributes) must be a hash in `PharmaObservatory::CompanyFinancialsRow` initialize method"
|
|
328
|
+
end
|
|
329
|
+
|
|
330
|
+
# check to see if the attribute exists and convert string to symbol for hash key
|
|
331
|
+
acceptable_attribute_map = self.class.acceptable_attribute_map
|
|
332
|
+
attributes = attributes.each_with_object({}) { |(k, v), h|
|
|
333
|
+
if (!acceptable_attribute_map.key?(k.to_sym))
|
|
334
|
+
fail ArgumentError, "`#{k}` is not a valid attribute in `PharmaObservatory::CompanyFinancialsRow`. Please check the name to make sure it's valid. List of attributes: " + acceptable_attribute_map.keys.inspect
|
|
335
|
+
end
|
|
336
|
+
h[k.to_sym] = v
|
|
337
|
+
}
|
|
338
|
+
|
|
339
|
+
if attributes.key?(:'company_id')
|
|
340
|
+
self.company_id = attributes[:'company_id']
|
|
341
|
+
end
|
|
342
|
+
|
|
343
|
+
if attributes.key?(:'company_name')
|
|
344
|
+
self.company_name = attributes[:'company_name']
|
|
345
|
+
end
|
|
346
|
+
|
|
347
|
+
if attributes.key?(:'group_id')
|
|
348
|
+
self.group_id = attributes[:'group_id']
|
|
349
|
+
end
|
|
350
|
+
|
|
351
|
+
if attributes.key?(:'group_name')
|
|
352
|
+
self.group_name = attributes[:'group_name']
|
|
353
|
+
end
|
|
354
|
+
|
|
355
|
+
if attributes.key?(:'reporting_org_id')
|
|
356
|
+
self.reporting_org_id = attributes[:'reporting_org_id']
|
|
357
|
+
end
|
|
358
|
+
|
|
359
|
+
if attributes.key?(:'fiscal_year')
|
|
360
|
+
self.fiscal_year = attributes[:'fiscal_year']
|
|
361
|
+
end
|
|
362
|
+
|
|
363
|
+
if attributes.key?(:'is_public')
|
|
364
|
+
self.is_public = attributes[:'is_public']
|
|
365
|
+
end
|
|
366
|
+
|
|
367
|
+
if attributes.key?(:'edgar_cik')
|
|
368
|
+
self.edgar_cik = attributes[:'edgar_cik']
|
|
369
|
+
end
|
|
370
|
+
|
|
371
|
+
if attributes.key?(:'ticker')
|
|
372
|
+
self.ticker = attributes[:'ticker']
|
|
373
|
+
end
|
|
374
|
+
|
|
375
|
+
if attributes.key?(:'exchange')
|
|
376
|
+
self.exchange = attributes[:'exchange']
|
|
377
|
+
end
|
|
378
|
+
|
|
379
|
+
if attributes.key?(:'public_float_usd')
|
|
380
|
+
self.public_float_usd = attributes[:'public_float_usd']
|
|
381
|
+
end
|
|
382
|
+
|
|
383
|
+
if attributes.key?(:'public_float_fy')
|
|
384
|
+
self.public_float_fy = attributes[:'public_float_fy']
|
|
385
|
+
end
|
|
386
|
+
|
|
387
|
+
if attributes.key?(:'latest_shares_outstanding')
|
|
388
|
+
self.latest_shares_outstanding = attributes[:'latest_shares_outstanding']
|
|
389
|
+
end
|
|
390
|
+
|
|
391
|
+
if attributes.key?(:'latest_shares_outstanding_fy')
|
|
392
|
+
self.latest_shares_outstanding_fy = attributes[:'latest_shares_outstanding_fy']
|
|
393
|
+
end
|
|
394
|
+
|
|
395
|
+
if attributes.key?(:'latest_financial_fy')
|
|
396
|
+
self.latest_financial_fy = attributes[:'latest_financial_fy']
|
|
397
|
+
end
|
|
398
|
+
|
|
399
|
+
if attributes.key?(:'revenue')
|
|
400
|
+
self.revenue = attributes[:'revenue']
|
|
401
|
+
end
|
|
402
|
+
|
|
403
|
+
if attributes.key?(:'net_income')
|
|
404
|
+
self.net_income = attributes[:'net_income']
|
|
405
|
+
end
|
|
406
|
+
|
|
407
|
+
if attributes.key?(:'rnd')
|
|
408
|
+
self.rnd = attributes[:'rnd']
|
|
409
|
+
end
|
|
410
|
+
|
|
411
|
+
if attributes.key?(:'assets')
|
|
412
|
+
self.assets = attributes[:'assets']
|
|
413
|
+
end
|
|
414
|
+
|
|
415
|
+
if attributes.key?(:'equity')
|
|
416
|
+
self.equity = attributes[:'equity']
|
|
417
|
+
end
|
|
418
|
+
|
|
419
|
+
if attributes.key?(:'public_float')
|
|
420
|
+
self.public_float = attributes[:'public_float']
|
|
421
|
+
end
|
|
422
|
+
|
|
423
|
+
if attributes.key?(:'cash')
|
|
424
|
+
self.cash = attributes[:'cash']
|
|
425
|
+
end
|
|
426
|
+
|
|
427
|
+
if attributes.key?(:'short_term_investments')
|
|
428
|
+
self.short_term_investments = attributes[:'short_term_investments']
|
|
429
|
+
end
|
|
430
|
+
|
|
431
|
+
if attributes.key?(:'cash_and_investments')
|
|
432
|
+
self.cash_and_investments = attributes[:'cash_and_investments']
|
|
433
|
+
end
|
|
434
|
+
|
|
435
|
+
if attributes.key?(:'operating_cash_flow')
|
|
436
|
+
self.operating_cash_flow = attributes[:'operating_cash_flow']
|
|
437
|
+
end
|
|
438
|
+
|
|
439
|
+
if attributes.key?(:'shares_outstanding')
|
|
440
|
+
self.shares_outstanding = attributes[:'shares_outstanding']
|
|
441
|
+
end
|
|
442
|
+
|
|
443
|
+
if attributes.key?(:'stock_based_compensation')
|
|
444
|
+
self.stock_based_compensation = attributes[:'stock_based_compensation']
|
|
445
|
+
end
|
|
446
|
+
|
|
447
|
+
if attributes.key?(:'operating_expenses')
|
|
448
|
+
self.operating_expenses = attributes[:'operating_expenses']
|
|
449
|
+
end
|
|
450
|
+
|
|
451
|
+
if attributes.key?(:'dividends_paid')
|
|
452
|
+
self.dividends_paid = attributes[:'dividends_paid']
|
|
453
|
+
end
|
|
454
|
+
|
|
455
|
+
if attributes.key?(:'eps_basic')
|
|
456
|
+
self.eps_basic = attributes[:'eps_basic']
|
|
457
|
+
end
|
|
458
|
+
|
|
459
|
+
if attributes.key?(:'eps_diluted')
|
|
460
|
+
self.eps_diluted = attributes[:'eps_diluted']
|
|
461
|
+
end
|
|
462
|
+
|
|
463
|
+
if attributes.key?(:'total_liabilities')
|
|
464
|
+
self.total_liabilities = attributes[:'total_liabilities']
|
|
465
|
+
end
|
|
466
|
+
|
|
467
|
+
if attributes.key?(:'long_term_debt_noncurrent')
|
|
468
|
+
self.long_term_debt_noncurrent = attributes[:'long_term_debt_noncurrent']
|
|
469
|
+
end
|
|
470
|
+
|
|
471
|
+
if attributes.key?(:'long_term_debt_total')
|
|
472
|
+
self.long_term_debt_total = attributes[:'long_term_debt_total']
|
|
473
|
+
end
|
|
474
|
+
|
|
475
|
+
if attributes.key?(:'intangible_assets')
|
|
476
|
+
self.intangible_assets = attributes[:'intangible_assets']
|
|
477
|
+
end
|
|
478
|
+
|
|
479
|
+
if attributes.key?(:'property_plant_equipment')
|
|
480
|
+
self.property_plant_equipment = attributes[:'property_plant_equipment']
|
|
481
|
+
end
|
|
482
|
+
|
|
483
|
+
if attributes.key?(:'goodwill')
|
|
484
|
+
self.goodwill = attributes[:'goodwill']
|
|
485
|
+
end
|
|
486
|
+
|
|
487
|
+
if attributes.key?(:'inventory')
|
|
488
|
+
self.inventory = attributes[:'inventory']
|
|
489
|
+
end
|
|
490
|
+
|
|
491
|
+
if attributes.key?(:'accounts_payable')
|
|
492
|
+
self.accounts_payable = attributes[:'accounts_payable']
|
|
493
|
+
end
|
|
494
|
+
|
|
495
|
+
if attributes.key?(:'accounts_receivable')
|
|
496
|
+
self.accounts_receivable = attributes[:'accounts_receivable']
|
|
497
|
+
end
|
|
498
|
+
|
|
499
|
+
if attributes.key?(:'weighted_average_shares_basic')
|
|
500
|
+
self.weighted_average_shares_basic = attributes[:'weighted_average_shares_basic']
|
|
501
|
+
end
|
|
502
|
+
|
|
503
|
+
if attributes.key?(:'weighted_average_shares_diluted')
|
|
504
|
+
self.weighted_average_shares_diluted = attributes[:'weighted_average_shares_diluted']
|
|
505
|
+
end
|
|
506
|
+
|
|
507
|
+
if attributes.key?(:'burn_basis_usd')
|
|
508
|
+
self.burn_basis_usd = attributes[:'burn_basis_usd']
|
|
509
|
+
end
|
|
510
|
+
|
|
511
|
+
if attributes.key?(:'burn_basis_years')
|
|
512
|
+
self.burn_basis_years = attributes[:'burn_basis_years']
|
|
513
|
+
end
|
|
514
|
+
|
|
515
|
+
if attributes.key?(:'runway_months')
|
|
516
|
+
self.runway_months = attributes[:'runway_months']
|
|
517
|
+
end
|
|
518
|
+
|
|
519
|
+
if attributes.key?(:'sec_total_revenue_usd_millions')
|
|
520
|
+
self.sec_total_revenue_usd_millions = attributes[:'sec_total_revenue_usd_millions']
|
|
521
|
+
end
|
|
522
|
+
end
|
|
523
|
+
|
|
524
|
+
# Show invalid properties with the reasons. Usually used together with valid?
|
|
525
|
+
# @return Array for valid properties with the reasons
|
|
526
|
+
def list_invalid_properties
|
|
527
|
+
warn '[DEPRECATED] the `list_invalid_properties` method is obsolete'
|
|
528
|
+
invalid_properties = Array.new
|
|
529
|
+
invalid_properties
|
|
530
|
+
end
|
|
531
|
+
|
|
532
|
+
# Check to see if the all the properties in the model are valid
|
|
533
|
+
# @return true if the model is valid
|
|
534
|
+
def valid?
|
|
535
|
+
warn '[DEPRECATED] the `valid?` method is obsolete'
|
|
536
|
+
true
|
|
537
|
+
end
|
|
538
|
+
|
|
539
|
+
# Checks equality by comparing each attribute.
|
|
540
|
+
# @param [Object] Object to be compared
|
|
541
|
+
def ==(o)
|
|
542
|
+
return true if self.equal?(o)
|
|
543
|
+
self.class == o.class &&
|
|
544
|
+
company_id == o.company_id &&
|
|
545
|
+
company_name == o.company_name &&
|
|
546
|
+
group_id == o.group_id &&
|
|
547
|
+
group_name == o.group_name &&
|
|
548
|
+
reporting_org_id == o.reporting_org_id &&
|
|
549
|
+
fiscal_year == o.fiscal_year &&
|
|
550
|
+
is_public == o.is_public &&
|
|
551
|
+
edgar_cik == o.edgar_cik &&
|
|
552
|
+
ticker == o.ticker &&
|
|
553
|
+
exchange == o.exchange &&
|
|
554
|
+
public_float_usd == o.public_float_usd &&
|
|
555
|
+
public_float_fy == o.public_float_fy &&
|
|
556
|
+
latest_shares_outstanding == o.latest_shares_outstanding &&
|
|
557
|
+
latest_shares_outstanding_fy == o.latest_shares_outstanding_fy &&
|
|
558
|
+
latest_financial_fy == o.latest_financial_fy &&
|
|
559
|
+
revenue == o.revenue &&
|
|
560
|
+
net_income == o.net_income &&
|
|
561
|
+
rnd == o.rnd &&
|
|
562
|
+
assets == o.assets &&
|
|
563
|
+
equity == o.equity &&
|
|
564
|
+
public_float == o.public_float &&
|
|
565
|
+
cash == o.cash &&
|
|
566
|
+
short_term_investments == o.short_term_investments &&
|
|
567
|
+
cash_and_investments == o.cash_and_investments &&
|
|
568
|
+
operating_cash_flow == o.operating_cash_flow &&
|
|
569
|
+
shares_outstanding == o.shares_outstanding &&
|
|
570
|
+
stock_based_compensation == o.stock_based_compensation &&
|
|
571
|
+
operating_expenses == o.operating_expenses &&
|
|
572
|
+
dividends_paid == o.dividends_paid &&
|
|
573
|
+
eps_basic == o.eps_basic &&
|
|
574
|
+
eps_diluted == o.eps_diluted &&
|
|
575
|
+
total_liabilities == o.total_liabilities &&
|
|
576
|
+
long_term_debt_noncurrent == o.long_term_debt_noncurrent &&
|
|
577
|
+
long_term_debt_total == o.long_term_debt_total &&
|
|
578
|
+
intangible_assets == o.intangible_assets &&
|
|
579
|
+
property_plant_equipment == o.property_plant_equipment &&
|
|
580
|
+
goodwill == o.goodwill &&
|
|
581
|
+
inventory == o.inventory &&
|
|
582
|
+
accounts_payable == o.accounts_payable &&
|
|
583
|
+
accounts_receivable == o.accounts_receivable &&
|
|
584
|
+
weighted_average_shares_basic == o.weighted_average_shares_basic &&
|
|
585
|
+
weighted_average_shares_diluted == o.weighted_average_shares_diluted &&
|
|
586
|
+
burn_basis_usd == o.burn_basis_usd &&
|
|
587
|
+
burn_basis_years == o.burn_basis_years &&
|
|
588
|
+
runway_months == o.runway_months &&
|
|
589
|
+
sec_total_revenue_usd_millions == o.sec_total_revenue_usd_millions
|
|
590
|
+
end
|
|
591
|
+
|
|
592
|
+
# @see the `==` method
|
|
593
|
+
# @param [Object] Object to be compared
|
|
594
|
+
def eql?(o)
|
|
595
|
+
self == o
|
|
596
|
+
end
|
|
597
|
+
|
|
598
|
+
# Calculates hash code according to all attributes.
|
|
599
|
+
# @return [Integer] Hash code
|
|
600
|
+
def hash
|
|
601
|
+
[company_id, company_name, group_id, group_name, reporting_org_id, fiscal_year, is_public, edgar_cik, ticker, exchange, public_float_usd, public_float_fy, latest_shares_outstanding, latest_shares_outstanding_fy, latest_financial_fy, revenue, net_income, rnd, assets, equity, public_float, cash, short_term_investments, cash_and_investments, operating_cash_flow, shares_outstanding, stock_based_compensation, operating_expenses, dividends_paid, eps_basic, eps_diluted, total_liabilities, long_term_debt_noncurrent, long_term_debt_total, intangible_assets, property_plant_equipment, goodwill, inventory, accounts_payable, accounts_receivable, weighted_average_shares_basic, weighted_average_shares_diluted, burn_basis_usd, burn_basis_years, runway_months, sec_total_revenue_usd_millions].hash
|
|
602
|
+
end
|
|
603
|
+
|
|
604
|
+
# Builds the object from hash
|
|
605
|
+
# @param [Hash] attributes Model attributes in the form of hash
|
|
606
|
+
# @return [Object] Returns the model itself
|
|
607
|
+
def self.build_from_hash(attributes)
|
|
608
|
+
return nil unless attributes.is_a?(Hash)
|
|
609
|
+
attributes = attributes.transform_keys(&:to_sym)
|
|
610
|
+
transformed_hash = {}
|
|
611
|
+
openapi_types.each_pair do |key, type|
|
|
612
|
+
if attributes.key?(attribute_map[key]) && attributes[attribute_map[key]].nil?
|
|
613
|
+
transformed_hash["#{key}"] = nil
|
|
614
|
+
elsif type =~ /\AArray<(.*)>/i
|
|
615
|
+
# check to ensure the input is an array given that the attribute
|
|
616
|
+
# is documented as an array but the input is not
|
|
617
|
+
if attributes[attribute_map[key]].is_a?(Array)
|
|
618
|
+
transformed_hash["#{key}"] = attributes[attribute_map[key]].map { |v| _deserialize($1, v) }
|
|
619
|
+
end
|
|
620
|
+
elsif !attributes[attribute_map[key]].nil?
|
|
621
|
+
transformed_hash["#{key}"] = _deserialize(type, attributes[attribute_map[key]])
|
|
622
|
+
end
|
|
623
|
+
end
|
|
624
|
+
new(transformed_hash)
|
|
625
|
+
end
|
|
626
|
+
|
|
627
|
+
# Deserializes the data based on type
|
|
628
|
+
# @param string type Data type
|
|
629
|
+
# @param string value Value to be deserialized
|
|
630
|
+
# @return [Object] Deserialized data
|
|
631
|
+
def self._deserialize(type, value)
|
|
632
|
+
case type.to_sym
|
|
633
|
+
when :Time
|
|
634
|
+
Time.parse(value)
|
|
635
|
+
when :Date
|
|
636
|
+
Date.parse(value)
|
|
637
|
+
when :String
|
|
638
|
+
value.to_s
|
|
639
|
+
when :Integer
|
|
640
|
+
value.to_i
|
|
641
|
+
when :Float
|
|
642
|
+
value.to_f
|
|
643
|
+
when :Boolean
|
|
644
|
+
if value.to_s =~ /\A(true|t|yes|y|1)\z/i
|
|
645
|
+
true
|
|
646
|
+
else
|
|
647
|
+
false
|
|
648
|
+
end
|
|
649
|
+
when :Object
|
|
650
|
+
# generic object (usually a Hash), return directly
|
|
651
|
+
value
|
|
652
|
+
when /\AArray<(?<inner_type>.+)>\z/
|
|
653
|
+
inner_type = Regexp.last_match[:inner_type]
|
|
654
|
+
value.map { |v| _deserialize(inner_type, v) }
|
|
655
|
+
when /\AHash<(?<k_type>.+?), (?<v_type>.+)>\z/
|
|
656
|
+
k_type = Regexp.last_match[:k_type]
|
|
657
|
+
v_type = Regexp.last_match[:v_type]
|
|
658
|
+
{}.tap do |hash|
|
|
659
|
+
value.each do |k, v|
|
|
660
|
+
hash[_deserialize(k_type, k)] = _deserialize(v_type, v)
|
|
661
|
+
end
|
|
662
|
+
end
|
|
663
|
+
else # model
|
|
664
|
+
# models (e.g. Pet) or oneOf
|
|
665
|
+
klass = PharmaObservatory.const_get(type)
|
|
666
|
+
klass.respond_to?(:openapi_any_of) || klass.respond_to?(:openapi_one_of) ? klass.build(value) : klass.build_from_hash(value)
|
|
667
|
+
end
|
|
668
|
+
end
|
|
669
|
+
|
|
670
|
+
# Returns the string representation of the object
|
|
671
|
+
# @return [String] String presentation of the object
|
|
672
|
+
def to_s
|
|
673
|
+
to_hash.to_s
|
|
674
|
+
end
|
|
675
|
+
|
|
676
|
+
# to_body is an alias to to_hash (backward compatibility)
|
|
677
|
+
# @return [Hash] Returns the object in the form of hash
|
|
678
|
+
def to_body
|
|
679
|
+
to_hash
|
|
680
|
+
end
|
|
681
|
+
|
|
682
|
+
# Returns the object in the form of hash
|
|
683
|
+
# @return [Hash] Returns the object in the form of hash
|
|
684
|
+
def to_hash
|
|
685
|
+
hash = {}
|
|
686
|
+
self.class.attribute_map.each_pair do |attr, param|
|
|
687
|
+
value = self.send(attr)
|
|
688
|
+
if value.nil?
|
|
689
|
+
is_nullable = self.class.openapi_nullable.include?(attr)
|
|
690
|
+
next if !is_nullable || (is_nullable && !instance_variable_defined?(:"@#{attr}"))
|
|
691
|
+
end
|
|
692
|
+
|
|
693
|
+
hash[param] = _to_hash(value)
|
|
694
|
+
end
|
|
695
|
+
hash
|
|
696
|
+
end
|
|
697
|
+
|
|
698
|
+
# Outputs non-array value in the form of hash
|
|
699
|
+
# For object, use to_hash. Otherwise, just return the value
|
|
700
|
+
# @param [Object] value Any valid value
|
|
701
|
+
# @return [Hash] Returns the value in the form of hash
|
|
702
|
+
def _to_hash(value)
|
|
703
|
+
if value.is_a?(Array)
|
|
704
|
+
value.compact.map { |v| _to_hash(v) }
|
|
705
|
+
elsif value.is_a?(Hash)
|
|
706
|
+
{}.tap do |hash|
|
|
707
|
+
value.each { |k, v| hash[k] = _to_hash(v) }
|
|
708
|
+
end
|
|
709
|
+
elsif value.respond_to? :to_hash
|
|
710
|
+
value.to_hash
|
|
711
|
+
else
|
|
712
|
+
value
|
|
713
|
+
end
|
|
714
|
+
end
|
|
715
|
+
|
|
716
|
+
end
|
|
717
|
+
|
|
718
|
+
end
|